Literature DB >> 3536896

Cloning and expression of human lymphotoxin mRNA derived from a human T cell hybridoma.

Y Kobayashi, D Miyamoto, M Asada, M Obinata, T Osawa.   

Abstract

We cloned human lymphotoxin (LT) cDNA from a cDNA library prepared from phorbol myristate acetate (PMA) and Con A-stimulated human T cell hybridoma (AC5-8) cells, The nucleotide sequence of the cDNA insert in the plasmid, pLT13, was determined and compared with those of peripheral blood mononuclear cell derived LT cDNA and the LT gene. Four stretches, containing 14 nucleotides in total, were different among the three sequences. The differences included one base change from C to A in the coding region. Because this change was expected to result in a change in the amino acid at position 26 from Thr to Asn, we constructed an E. coli expression plasmid (pLT13tac6-8.2) and a mammalian cell expression plasmid (pSV2-LT) in order to confirm that pLT13 contains the coding sequence of human LT. Both plasmids were found to synthesize active LT molecules after transfection into JM105 and COS-1 cells, respectively, and their lytic activities were found to be completely neutralized by anti human LT serum. Using an insertion mutant and a deletion mutant, we examined the role of the C terminal domain in the LT activity. The results obtained strongly suggested that the intactness of the C terminal less than 10 residues is required for the LT activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536896     DOI: 10.1093/oxfordjournals.jbchem.a121765

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  6 in total

1.  A stimulation-dependent alternate core promoter links lymphotoxin α expression with TGF-β1 and fibroblast growth factor-7 signaling in primary human T cells.

Authors:  Brian H Yokley; Sandra T Selby; Phillip E Posch
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

2.  Production of lymphotoxin and tumour necrosis factor by a T-cell hybridoma.

Authors:  Y Kobayashi; M Asada; T Osawa
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

3.  Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity.

Authors:  D A Rathjen; A Ferrante; R Aston
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

4.  A human macrophage hybridoma producing a cytotoxic factor distinct from TNF, LT, and IL-1.

Authors:  O Shimoda; Y Takeda; H J Woo; S Shimada; M Higuchi; T Osawa
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.

Authors:  G Messer; U Spengler; M C Jung; G Honold; K Blömer; G R Pape; G Riethmüller; E H Weiss
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

6.  Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Amina R Gani; Mohmmad Shoab Mansuri; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.